文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症医学研究议程:多重耐药菌、抗生素与抗菌药物管理

The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.
PubMed 文献 · Intensive Care Med · 2017-02-04
一句话结论本综述提出未来十年ICU多重耐药菌防控、抗生素优化使用及抗菌药物管理的关键研究方向,强调需临床研究验证。

本文为叙述性综述,基于对医学文献、国家和国际指南及专家意见的系统分析,描述ICU中多重耐药(MDR)细菌感染、抗生素使用和抗菌药物管理的当前标准、近期进展、被近期试验推翻的常见观念、不确定性领域及未来十年需开展的临床研究。综述指出,ICU危重患者MDR细菌感染患病率正快速演变,亟需临床研究了解其变化模式;理想抗生素使用需进一步研究剂量优化、疗程、联合治疗、雾化抗生素及快速诊断整合;需开发非抗生素方法预防和治疗ICU MDR感染;需临床研究证明ICU抗菌药物管理的获益。结论强调未来十年需解决这些基本问题以更好预防、诊断和治疗MDR细菌感染。

要点

  • ICU危重患者MDR细菌感染患病率正快速演变,亟需临床研究了解其变化模式。
  • 理想抗生素使用存在不确定性,需研究剂量优化、疗程、联合治疗、雾化抗生素及快速诊断整合。
  • 亟需开发非抗生素方法用于ICU中MDR感染的预防和治疗。
  • 需临床研究证明ICU抗菌药物管理的获益。
  • 未来十年需解决上述基本问题以更好预防、诊断和治疗MDR细菌感染。

适用人群与场景

  • ICU危重患者,涉及MDR细菌感染、抗生素使用和抗菌药物管理。

研究设计与关键结果

  • 综述方法:基于对医学文献、国家和国际指南及专家意见的系统分析的叙述性综述。
  • 主要发现:ICU危重患者MDR细菌感染患病率正快速演变;理想抗生素使用存在不确定性,需研究剂量优化、疗程、联合治疗、雾化抗生素及快速诊断整合;亟需开发非抗生素方法预防和治疗ICU MDR感染;需临床研究证明ICU抗菌药物管理的获益。

证据类型、等级与局限

  • 证据类型:叙述性综述,基于系统分析的医学文献、国家和国际指南及专家意见。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To concisely describe the current standards of care, major recent advances, common beliefs that have been contradicted by recent trials, areas of uncertainty, and clinical studies that need to be performed over the next decade and their expected outcomes with regard to the management of multidrug-resistant (MDR) bacteria, antibiotic use, and antimicrobial stewardship in the intensive care unit (ICU) setting.

METHODS: Narrative review based on a systematic analysis of the medical literature, national and international guidelines, and expert opinion.

RESULTS: The prevalence of infection of critically ill patients by MDR bacteria is rapidly evolving. Clinical studies aimed at improving understanding of the changing patterns of these infections in ICUs are urgently needed. Ideal antibiotic utilization is another area of uncertainty requiring additional investigations aimed at better understanding of dose optimization, duration of therapy, use of combination treatment, aerosolized antibiotics, and the integration of rapid diagnostics as a guide for treatment. Moreover, there is an imperative need to develop non-antibiotic approaches for the prevention and treatment of MDR infections in the ICU. Finally, clinical research aimed at demonstrating the beneficial impact of antimicrobial stewardship in the ICU setting is essential.

CONCLUSIONS: These and other fundamental questions need to be addressed over the next decade in order to better understand how to prevent, diagnose, and treat MDR bacterial infections. Clinical studies described in this research agenda provide a template and set priorities for investigations that should be performed in this field.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017. PMID: 28160023. doi:10.1007/s00134-017-4682-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。